[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1015 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 1015
To amend title 18, United States Code, to provide for certain rules for
housing or transportation based on gender and to provide for a
limitation on gender-related medical treatment.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 5, 2025
Ms. Mace (for herself, Mr. Nehls, Mr. Donalds, and Ms. Boebert)
introduced the following bill; which was referred to the Committee on
the Judiciary
_______________________________________________________________________
A BILL
To amend title 18, United States Code, to provide for certain rules for
housing or transportation based on gender and to provide for a
limitation on gender-related medical treatment.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Prison Rape Prevention Act of
2025''.
SEC. 2. RULES FOR HOUSING OR TRANSPORTATION BASED ON GENDER; LIMITATION
ON GENDER-AFFIRMING CARE.
Section 3621 of title 18, United States Code, is amended by adding
at the end the following:
``(j) Rules for Housing or Transportation Based on Gender;
Limitation on Gender-Affirming Care.--Notwithstanding any other
provision of law, the Bureau of Prisons--
``(1) shall ensure that a prisoner is placed, during that
prisoner's term of imprisonment, only among prisoners of the
same biological sex as the prisoner;
``(2) shall ensure that a prisoner, when transported in the
company of other prisoners, is only transported among prisoners
of the same biological sex as the prisoner; and
``(3) may not furnish or pay for any gender-related medical
treatment.
``(k) Definitions.--For purposes of subsection (j):
``(1) Biological sex.--The term `biological sex' means the
biological determination as to whether an individual is male or
female.
``(2) Female.--The term `female' means an individual who
naturally has, had, will have, or would have, but for a
developmental or genetic anomaly or historical accident, the
reproductive system that at some point produces, transports,
and utilizes eggs for fertilization.
``(3) Male.--The term `male' means an individual who
naturally has, had, will have, or would have, but for a
developmental or genetic anomaly or historical accident, the
reproductive system that at some point produces, transports,
and utilizes sperm for fertilization.
``(4) Gender.--The term `gender'--
``(A) means--
``(i) males, females, or the natural
differences between males and females, unless
such term is otherwise specified or used alone
(rather than with or as an adjective modifying
other words); and
``(ii) a synonym for sex; and
``(B) does not mean a synonym for terms or ideas
such as gender identity, experienced gender, gender
expression, or gender roles
``(5) Gender-related medical treatment.--The term `gender-
related medical treatment'--
``(A) means--
``(i) with respect to a female individual,
medical treatments provided for purposes of
addressing the perception of such individual
that the gender or sex of such individual is
not female, including--
``(I) surgical procedures,
including--
``(aa) vaginectomy;
``(bb) hysterectomy;
``(cc) oophorectomy;
``(dd) reconstruction of
the urethra;
``(ee) metoidioplasty;
``(ff) phalloplasty;
``(gg) salpingo-
oophorectomy;
``(hh) scrotoplasty;
``(ii) implantation of
erection or testicular
protheses;
``(jj) subcutaneous
mastectomy;
``(kk) vocal cord surgery;
``(ll) pectoral implants;
and
``(mm) penile
transplantation;
``(II) exogenous doses of
testosterone or other androgens;
``(III) puberty blockers,
including--
``(aa) GnRH agonists; and
``(bb) synthetic drugs that
suppress the production of
estrogen and progesterone or
delay or suppress pubertal
development in female
individuals; and
``(IV) such other medical
treatment, identified by the Director
of the Federal Bureau of Prisons, that
may be provided for purposes of
addressing the perception of such
individual that the gender or sex of
such individual is not female; and
``(ii) with respect to a male individual,
medical treatments provided for purposes of
addressing the perception of such individual
that the gender or sex of such individual is
not male, including--
``(I) surgical procedures,
including--
``(aa) penectomy;
``(bb) orchiectomy;
``(cc) vaginoplasty;
``(dd) clitoroplasty;
``(ee) vulvoplasty;
``(ff) augmentation
mammoplasty;
``(gg) facial feminization
surgery;
``(hh) vocal cord surgery;
``(ii)
chondrolaryngoplasty;
``(jj) gluteal
augmentation; and
``(kk) uterine
transplantation;
``(II) exogenous doses of estrogen;
``(III) puberty blockers,
including--
``(aa) GnRH agonists; and
``(bb) synthetic drugs that
suppress the production of
testosterone or delay or
suppress pubertal development
in male individuals; and
``(IV) such other medical
treatment, identified by the Director
of the Federal Bureau of Prisons, that
may be provided for purposes of
addressing the perception of such
individual that the gender or sex of
such individual is not male; and
``(B) does not include any medical treament
performed on an individual for the purposes of
treating--
``(i) a disorder of sex development,
diagnosed by a physician after such physician
has determined through genetic or biochemical
testing that such individual does not have
normal sex chromosome structure, sex steroid
hormone production, or sex steroid hormone
action;
``(ii) irresolvably ambiguous biological
sex characteristics of such individual,
including the presence of--
``(I) 46 XX chromosomes with
virilization;
``(II) 46 XY chromosomes with
undervirilization; or
``(III) both ovarian and testicular
tissue; or
``(iii) an infection, injury, disease, or
disorder caused or exacerbated by gender-
related medical treatment that was furnished to
an individual.''.
<all>